As of 2026-05-20, the Relative Valuation of Recro Pharma Inc (REPH) is (3.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.09 USD, the upside of Recro Pharma Inc based on Relative Valuation is -247.9%.
The range of the Relative Valuation is (1.27) - (3.51) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.2x - 19.7x | 14.0x |
| Forward P/E multiples | 5.2x - 14.5x | 11.5x |
| Fair Price | (1.27) - (3.51) | (3.09) |
| Upside | -160.7% - -268.1% | -247.9% |
| Date | P/E |